Skip to main content
Log in

Liver abscess after transcatheter arterial chemoembolization for hepatocellular carcinoma: clinical manifestations, risk factors, diagnosis, prevention, and treatment

  • Review
  • Published:
Chinese Journal of Academic Radiology Aims and scope Submit manuscript

Abstract

Transcatheter arterial chemoembolization (TACE) is the recommended first-line treatment for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma. However, TACE is associated with several major complications, such as liver abscess. Although liver abscess is an uncommon complication of TACE, it is associated with a high mortality rate. Early diagnosis and treatment of this complication are the keys to reducing the mortality rate and the length of hospital stay. However, no guidelines exist to guide the management of liver abscess after TACE. Herein, we review the clinical manifestations, risk factors, prevention, diagnosis, and treatment of liver abscess after TACE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Availability of data and material

All data generated or analyzed during this study are included in this published article.

Code availability

Not applicable.

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.

    Article  CAS  PubMed  Google Scholar 

  2. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74. https://doi.org/10.1055/s-0030-1247133.

    Article  CAS  PubMed  Google Scholar 

  3. Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, Lee HS, Kim CY. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol. 2001;12(3):313–20. https://doi.org/10.1016/s1051-0443(07)61910-1.

    Article  CAS  PubMed  Google Scholar 

  4. Lv WF, Lu D, He YS, Xiao JK, Zhou CZ, Cheng DL. Liver abscess formation following transarterial chemoembolization: clinical features, risk factors, bacteria spectrum, and percutaneous catheter drainage. Medicine. 2016;95(17): e3503. https://doi.org/10.1097/md.0000000000003503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Chen C, Chen PJ, Yang PM, Huang GT, Lai MY, Tsang YM, Chen DS. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997;92(12):2257–9.

    CAS  PubMed  Google Scholar 

  6. Cheng D. Liver abscess following transarterial chemoembolization. Semin Interv Radiol. 2011;28(4):450–6. https://doi.org/10.1055/s-0031-1296088.

    Article  Google Scholar 

  7. Shin JU, Kim KM, Shin SW, Min SY, Park SU, Sinn DH, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC, Koh KC. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis. 2014;46(9):813–7. https://doi.org/10.1016/j.dld.2014.05.003.

    Article  PubMed  Google Scholar 

  8. Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma. Medicine. 2016;95(49): e5606. https://doi.org/10.1097/md.0000000000005606.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Santos-Rosa OM, Lunardelli HS, Ribeiro-Junior MA. Pyogenic liver abscess: diagnostic and therapeutic management. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2016;29(3):194–7. https://doi.org/10.1590/0102-6720201600030015.

    Article  Google Scholar 

  10. Akhondi H, Sabih DE. Liver Abscess. StatPearls. Treasure Island: StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC.; 2020.

  11. Mischnik A, Kern WV, Thimme R. Pyogenic liver abscess: changes of organisms and consequences for diagnosis and therapy. Deutsche medizinische Wochenschrift (1946). 2017;142(14):1067–74. https://doi.org/10.1055/s-0043-100540.

    Article  Google Scholar 

  12. Woo S, Chung JW, Hur S, Joo SM, Kim HC, Jae HJ, Park JH. Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors. Am J Roentgenol. 2013;200(6):1370–7. https://doi.org/10.2214/ajr.12.9630.

    Article  Google Scholar 

  13. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12(8):965–8. https://doi.org/10.1016/s1051-0443(07)61577-2.

    Article  CAS  PubMed  Google Scholar 

  14. Wang YL, Song W, Bian YT, Pan M, Li FZ, Cui J. CalliSpheres drug-eluting beads versus convetional transarterial Chemoembolization (TACE) in the treatment of hepatocelluar carcinoma: clinical efficacy and safety comparative study. J Clini Radiol. 2020;39(09):185–91. https://doi.org/10.13437/j.cnki.jcr.2020.09.039.

    Article  Google Scholar 

  15. Zipori Y, Berger H, Colak E, Geary M. Pyogenic liver abscess with atypical microbiology during pregnancy. A case report. J Obstet Gynaecol. 2017;37(6):827–8. https://doi.org/10.1080/01443615.2017.1306032.

    Article  PubMed  Google Scholar 

  16. Du ZQ, Lu Q, Liu XM, Lyu Y, Zhang XF. Curative effect comparison of percutaneous puncture drainage and incision drainage for huge bacterial liver abscess. Chin J Hepatic Surg (Electron Ed). 2015;4(06):348–51.

    Google Scholar 

  17. Luo M, Yang XX, Tan B, Zhou XP, Xia HM, Xue J, Xu J, Xu X, Qing Y, Li CR, Qiu JF, Li YL. Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2016;35(10):1557–65. https://doi.org/10.1007/s10096-016-2712-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Liu L, Chen W, Lu X, Zhang K, Zhu C. Pyogenic liver abscess: a retrospective study of 105 cases in an emergency department from East China. J Emerg Med. 2017;52(4):409–16. https://doi.org/10.1016/j.jemermed.2016.09.026.

    Article  PubMed  Google Scholar 

  19. Huang SF, Ko CW, Chang CS, Chen GH. Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor. Hepatogastroenterology. 2003;50(52):1115–8.

    PubMed  Google Scholar 

  20. Ying ML, Xu SL, Xiao WB, Pan JF, Liu Q. Differential diagnostic value of diffusion weighted imaging on hepatic abscess and necrotic or cystic hepatic tumors. J Med Imaging. 2015;25(01):102–6.

    Google Scholar 

  21. Jia Z, Tu J, Cao C, Wang W, Zhou W, Ji J, Li M. Liver abscess following transarterial chemoembolization for the treatment of hepatocellular carcinoma: a retrospective analysis of 23 cases. J Cancer Res Ther. 2018;14(Supplement):S628–33. https://doi.org/10.4103/0973-1482.199385.

    Article  PubMed  Google Scholar 

  22. Han S, Ye Y, Wu J, Li B, Zhang G, Jin K, Tang R, Huang W, Chao M, Ding K. Procalcitonin levels in post TACE infection. Cancer Manag Res. 2020;12:12197–203. https://doi.org/10.2147/cmar.S281667.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Brown DB, Nikolic B, Covey AM, Nutting CW, Saad WE, Salem R, Sofocleous CT, Sze DY. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol. 2012;23(3):287–94. https://doi.org/10.1016/j.jvir.2011.11.029.

    Article  PubMed  Google Scholar 

  24. Patel S, Tuite CM, Mondschein JI, Soulen MC. Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention. J Vasc Interv Radiol. 2006;17(12):1931–4. https://doi.org/10.1097/01.Rvi.0000244854.79604.C1.

    Article  PubMed  Google Scholar 

  25. Shelgikar CS, Loehle J, Scoggins CR, McMasters KM, Martin RC 2nd. Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated? J Surg Res. 2009;151(1):121–4. https://doi.org/10.1016/j.jss.2008.02.039.

    Article  CAS  PubMed  Google Scholar 

  26. Watchmaker JM, Lipnik AJ, Fritsche MR, Baker JC, Mouli SK, Geevarghese S, et al. Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy? J Surg Oncol. 2018;117(6):1312–7. https://doi.org/10.1002/jso.24993.

    Article  CAS  PubMed  Google Scholar 

  27. Mansour MA, Khalifa MO. Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma. Arab J Gastroenterol. 2018;19(1):16–20. https://doi.org/10.1016/j.ajg.2018.02.002.

    Article  PubMed  Google Scholar 

  28. Yoshihara S, Yamana H, Akahane M, Kishimoto M, Nishioka Y, Noda T, Matsui H, Fushimi K, Yasunaga H, Kasahara K, Imamura T. Association between prophylactic antibiotic use for transarterial chemoembolization and occurrence of liver abscess: a retrospective cohort study. Clin Microbiol Infect. 2021. https://doi.org/10.1016/j.cmi.2021.01.014.

    Article  PubMed  Google Scholar 

  29. Huang RJ, Ambrosy AP, Triadafilopoulos G. Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma. Dig Dis Sci. 2013;58(9):2463–5. https://doi.org/10.1007/s10620-013-2593-1.

    Article  PubMed  Google Scholar 

  30. Mukthinuthalapati V, Attar BM, Parra-Rodriguez L, Cabrera NL, Araujo T, Gandhi S. Risk factors, management, and outcomes of pyogenic liver abscess in a US safety net hospital. Dig Dis Sci. 2020;65(5):1529–38. https://doi.org/10.1007/s10620-019-05851-9.

    Article  CAS  PubMed  Google Scholar 

  31. Neill L, Edwards F, Collin SM, Harrington D, Wakerley D, Rao GG, McGregor AC. Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess. BMC Infect Dis. 2019;19(1):490. https://doi.org/10.1186/s12879-019-4127-8.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hope WW, Vrochides DV, Newcomb WL, Mayo-Smith WW, Iannitti DA. Optimal treatment of hepatic abscess. Am Surg. 2008;74(2):178–82.

    Article  Google Scholar 

  33. Heneghan HM, Healy NA, Martin ST, Ryan RS, Nolan N, Traynor O, Waldron R. Modern management of pyogenic hepatic abscess: a case series and review of the literature. BMC Res Notes. 2011;4:80. https://doi.org/10.1186/1756-0500-4-80.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Okano H, Shiraki K, Inoue H, Kawakita T, Yamamoto N, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Nakano T. Clinicopathological analysis of liver abscess in Japan. Int J Mol Med. 2002;10(5):627–30.

    PubMed  Google Scholar 

  35. Serraino C, Elia C, Bracco C, Rinaldi G, Pomero F, Silvestri A, Melchio R, Fenoglio LM. Characteristics and management of pyogenic liver abscess: a European experience. Medicine. 2018;97(19): e0628. https://doi.org/10.1097/md.0000000000010628.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Wang WJ, Tao Z, Wu HL. Etiology and clinical manifestations of bacterial liver abscess: a study of 102 cases. Medicine. 2018;97(38): e12326. https://doi.org/10.1097/md.0000000000012326.

    Article  PubMed  PubMed Central  Google Scholar 

  37. De Jong KP, Prins TR, Hofker HS. A new interventional technique for percutaneous treatment of drainage-resistant liver abscess. Br J Radiol. 2010;83(993):e195–7. https://doi.org/10.1259/bjr/69471744.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Matoba M, Tonami H, Kuginuki M, Yamamoto I, Takashima S. Intermittent hepatic artery antibiotic infusion therapy for pyogenic hepatic abscess. Acta Radiol (Stockholm, Sweden: 1987). 2004;45(1):13–7. https://doi.org/10.1080/02841850410003518.

    Article  CAS  Google Scholar 

  39. Garcea G, Rajesh A, Dennison AR. Surgical management of cystic lesions in the liver. ANZ J Surg. 2013;83(7–8):E3–20. https://doi.org/10.1111/j.1445-2197.2012.06096.x.

    Article  PubMed  Google Scholar 

Download references

Funding

The authors did not receive support from any organization for the submitted work. No funding was received to assist with the preparation of this manuscript. No funding was received for conducting this study. No funds, grants, or other support was received.

Author information

Authors and Affiliations

Authors

Contributions

Each author has made an important scientific contribution to the study and is thoroughly familiar with the primary data.

Corresponding author

Correspondence to Xiao Li.

Ethics declarations

Conflict of interest

All authors declare that there are no conflict interest/competing interests to disclose.

Ethics approval

Waivers.

Consent to participate

Not applicable.

Consent for publication

Its publication in Chinese Journal of Academic Radiology has been approved by all authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, C., Tsauo, J. & Li, X. Liver abscess after transcatheter arterial chemoembolization for hepatocellular carcinoma: clinical manifestations, risk factors, diagnosis, prevention, and treatment. Chin J Acad Radiol 5, 69–73 (2022). https://doi.org/10.1007/s42058-022-00088-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42058-022-00088-4

Keywords

Navigation